/)
Regenerative medicine has become one of the most talked-about, and most over-promised, corners of men's health. Two approaches dominate the conversation: stem cell therapy and exosome therapy. Both aim to repair tissue at the cellular level rather than simply masking a symptom, and both are marketed heavily in Bangkok for erectile dysfunction (ED), recovery after prostate surgery, and general "anti-aging" vitality. The pitch is appealing. The evidence is more sober.
This guide is written for men who want a straight answer before spending real money. We cover how each therapy actually works, what the published research does and does not support, transparent Bangkok pricing in both THB and USD, who is and is not a candidate, the real risks, and how to tell a careful clinic from an opportunistic one. Throughout, we hedge to the evidence rather than the marketing, because the honest version is more useful than the hopeful one.
A note before we start: neither stem cells nor exosomes are an FDA-approved treatment for erectile dysfunction, and major urology and sexual-medicine bodies currently classify both as investigational. Any responsible version of these treatments begins with a medical consultation and a prescription-level decision made by a licensed doctor, not a menu price.
The Quick Orientation: Cells vs Messengers
The simplest way to hold the difference in your head:
Stem cells are living "master cells" that can, in theory, become other cell types and release repair signals. You are putting cells into the tissue.
Exosomes are the tiny packages (extracellular vesicles, roughly 30 to 150 nanometres) that stem cells naturally secrete. They carry proteins, growth factors, messenger RNA, and microRNA that tell nearby cells what to do. You are putting the signal in without the cell.
Researchers increasingly believe that much of what stem cells do for soft tissue comes not from the cells permanently engrafting and rebuilding, but from this paracrine signalling, the chemical messages they send to neighbouring cells. A 2024 update in the *Asian Journal of Urology* notes that stem cells secrete growth factors such as VEGF, IGF-1, and FGF-2 that drive nerve and vascular regeneration, and that exosome-based, cell-free therapy has shown effects in animal models through the same messaging pathway. That is the core idea behind exosome therapy: deliver the message, skip the cell.
What Is Stem Cell Therapy for Men?
Stem cell therapy uses mesenchymal stem cells (MSCs), versatile repair cells sourced from one of several places:
Bone marrow (autologous, from your own hip)
Adipose tissue (autologous, from your own fat via mini-liposuction)
Umbilical cord / Wharton's jelly (allogeneic, donor-derived; easier to scale but more tightly regulated)
For ED, the cells are injected into the erectile bodies of the penis (intracavernosal injection). The intended mechanism is regeneration of the cavernosal nerves, the endothelial lining of blood vessels, and the smooth muscle that lets the penis trap blood during an erection. The same logic underpins its use after radical prostatectomy, where nerve injury is a major cause of post-surgical ED.
What the evidence actually shows
This is where men deserve candour. A 2025 systematic review and meta-analysis in *BMC Urology* pooled the human trials and found that intracavernosal stem cell therapy produced statistically significant improvement at six months on validated measures (IIEF-5 erectile-function scores, peak systolic velocity on penile Doppler, and erection-hardness scores). That is genuinely encouraging.
The catch is durability. The same review found that benefit often diminished by 12 months, which the authors attribute to "limited stem cell survival or transient paracrine signalling rather than durable engraftment." Translated: the cells may not stick around, and the effect can fade. The overall human evidence base is also small. A separate 2024 review in the *Asian Journal of Urology* counted only about 11 published trials involving fewer than 130 patients combined, with inconsistent cell types, doses, and delivery methods, and the BMC 2025 analysis could pool roughly 75 patients across the trials it was able to meta-analyse. The reviewers' bottom line is consistent: larger, longer, properly randomised trials are still needed before this becomes a routine, recommended treatment.
What Is Exosome Therapy for Men?
Exosome therapy is "cell-free" regenerative medicine. Instead of injecting living cells, the clinic injects a purified preparation of the vesicles those cells secrete. A 2020 review in *World Journal of Stem Cells* describes MSC-derived exosomes as carrying "proteins, lipids, DNA, and RNA" that can "suppress apoptosis; promote cell regeneration and migration; regulate the immune and inflammatory responses; and promote angiogenesis, nerve regeneration, and tissue repair."
In men's health, exosomes are injected into penile tissue with the goal of stimulating new blood-vessel growth (angiogenesis) and reducing inflammation. The theoretical advantages over whole-cell therapy are real on paper: lower immunogenicity (less likely to trigger an immune reaction), greater stability for storage, and no risk of injected cells multiplying in unintended ways.
What the evidence actually shows
Here the honesty has to be sharper. Most exosome data for sexual function is preclinical, meaning animal and laboratory work, not human trials. There is no robust, published human ED trial base comparable even to the modest stem cell literature. And critically, the US FDA states there are no FDA-approved exosome products for any use, and has issued a public safety notification after serious adverse events in patients treated with unapproved exosome products. Exosomes intended to treat disease are regulated as drugs and biologics and require premarket approval the FDA says these clinics are skipping. That regulatory reality should weigh on any decision.
Stem Cells vs Exosomes: Side-by-Side
Feature | Stem Cell Therapy | Exosome Therapy |
What is injected | Living cells (bone marrow, fat, or cord-derived) | Cell-free vesicles secreted by stem cells |
Mechanism | Paracrine signalling plus possible direct regeneration | Paracrine signalling only (the messages, no cells) |
Human evidence (ED) | Small trials; short-term benefit, often fades by 6 to 12 months | Mostly preclinical; little published human ED data |
Procedure time | About 1 to 2 hours (longer if harvesting your own cells) | About 30 to 60 minutes |
Downtime | Minimal; some bruising/soreness | Minimal; some bruising/soreness |
Reported onset | Often 1 to 3 months | Often 2 to 6 weeks (clinic-reported, not trial-proven) |
Reported duration | Up to ~12 months, then decline in trials | Typically 6 to 12 months (clinic-reported) |
Regulatory status | Investigational; no FDA-approved product for ED | No FDA-approved exosome product for any use |
Relative cost | Higher | Lower |
The "onset" and "duration" figures circulating in clinic marketing are mostly internal observations, not outcomes from controlled trials. Treat them as expectations to test, not promises.
Which Is Better for Erectile Dysfunction?
There is no evidence-backed winner, because the comparative trials that would settle it have not been done. What can be said responsibly:
If you have moderate-to-severe ED with a likely nerve or tissue cause (for example, post-prostatectomy, long-standing diabetes), stem cells have the larger, if still limited, human evidence base and the stronger theoretical case for regeneration.
If you have milder, more vascular ED and want a lighter, lower-cost procedure, exosomes are the less invasive option, with the important caveat that human ED evidence is thinner and the regulatory status is weaker.
Combination protocols (stem cells plus exosomes, often alongside low-intensity shockwave therapy) are marketed as "maximum regeneration." They may be reasonable, but combining experimental therapies also stacks cost and uncertainty, and no trial has shown the combination beats either alone.
For most men, the medically sound sequence is to first exhaust proven options, oral PDE5 inhibitors, addressing testosterone and cardiovascular risk, and treating the conditions that cause ED, before paying for regenerative therapy as an adjunct. ED is frequently an early warning sign of vascular disease, so a proper workup matters more than the injection.
Beyond ED: Other Men's Health Uses
Both therapies are also marketed for:
Post-surgical recovery, particularly nerve-sparing prostatectomy rehabilitation
Hair restoration (exosomes are increasingly bundled into scalp protocols)
Joint and tendon repair in sports-injury contexts
General "vitality" and anti-aging packages
The same caveat applies across all of these: the strength of evidence varies enormously by indication, and "regenerative" is not a synonym for "proven." Ask what trial data supports the specific use you are paying for.
Bangkok Pricing: THB and USD, With the Savings Picture
Bangkok is one of Asia's busiest regenerative-medicine hubs, and pricing varies widely by cell source, dose (cell count), how many sessions are bundled, and whether shockwave or PRP is included. The figures below are indicative ranges drawn from current Bangkok clinic offerings and should be confirmed at consultation. They are not quotes.
Treatment (Bangkok) | Typical THB range | Approx. USD | Typical US/UK price | Indicative saving |
Exosome therapy, single session (ED) | ฿35,000 – 90,000 | $1,100 – 2,800 | $2,500 – 5,000 | ~40–60% |
Stem cell therapy, single protocol (ED) | ฿90,000 – 250,000 | $2,800 – 7,800 | $7,000 – 20,000+ | ~50–70% |
High-dose stem cell package (multi-day, 20M+ cells) | ฿250,000 – 550,000 | $7,800 – 17,200 | $15,000 – 30,000+ | ~50–60% |
Combination (stem cell + exosome + shockwave) | ฿150,000 – 350,000 | $4,700 – 10,900 | $12,000 – 25,000 | ~55–65% |
USD conversions use roughly ฿32 per USD and shift with exchange rates. The savings column compares Bangkok ranges with typical advertised US and UK pricing; it is a guide, not a guarantee. Always confirm exactly what is included (number of sessions, cell count, follow-up, imaging) before comparing two quotes, because a cheaper headline price often covers a smaller dose.
What drives the cost
Cell source and dose. Autologous bone-marrow or fat harvesting adds a procedure and lab time; higher cell counts (for example 20 million-plus) cost more. Donor cord-derived cells are priced differently again.
Lab processing and accreditation. Sterile, properly characterised preparations from an accredited lab cost more than cheap, unverified products, and that gap is exactly where safety lives.
Bundled add-ons. Shockwave courses, PRP, and follow-up Doppler imaging push the total up.
Physician expertise. A urologist-led protocol typically prices above a generic "wellness" injection, and usually for good reason.
Who Is a Candidate, and Who Is Not
These are elective, investigational treatments, so candidacy is as much about expectations as biology. A reasonable candidate is generally a man who:
Has ED that has been properly evaluated, with reversible and vascular causes addressed
Has realistic expectations and understands the evidence is preliminary
Has tried or considered standard treatments first
Is in good general health with no active infection at the injection site
Who should not proceed (contraindications and cautions)
Active cancer or a recent cancer history. Because these therapies stimulate cell growth and blood-vessel formation, men with active or recent malignancy are generally excluded. The FDA has cited tumour formation among reported harms from unapproved products.
Active infection, locally or systemically
Bleeding disorders or anticoagulation that is not managed for an injection procedure
Unrealistic or "cure" expectations, especially where ED has a clear psychological or medication cause that a regenerative injection will not fix
Anyone unwilling to first treat the underlying cardiovascular or metabolic disease that may be driving the ED
The decision to proceed, and the choice of source, dose, and protocol, requires a consultation and a prescription-level judgement from a licensed physician. There is no responsible "walk-in" version of this.
The Procedure and Recovery, Step by Step
While protocols differ, a careful course usually looks like this:
Consultation and workup. History, IIEF-5 questionnaire, hormone and metabolic labs, and often penile Doppler ultrasound to characterise blood flow. This is also where candidacy and contraindications are screened.
Preparation. For autologous stem cells, your bone marrow or fat is harvested and processed in the lab on the day or in advance. Exosomes arrive lab-prepared.
Injection. Under local anaesthetic or a penile block, the preparation is injected into the erectile bodies, sometimes guided by ultrasound.
Immediate aftercare. Brief observation, then home the same day.
Staged recovery
Day 0 to 3: Mild soreness, swelling, or bruising at injection sites. Avoid sexual activity and strenuous exercise as advised.
Week 1 to 2: Bruising resolves. Many clinics advise resuming normal activity and intimacy around this point.
Week 2 to 6: The window in which exosome patients are told to watch for early change.
Month 1 to 3: The window in which stem cell effects, if any, are expected to appear.
Month 6 to 12: Reassessment. Trial data suggests this is when any benefit may begin to plateau or decline, which is why honest clinics schedule follow-up rather than declaring victory at week two.
Have a question about your treatment?
Message our Bangkok clinic on WhatsApp and a doctor replies within minutes during clinic hours.
Quantified Expectations
To keep this grounded in real numbers rather than adjectives:
In the pooled human ED trials, improvement showed up at 6 months on IIEF-5, peak systolic velocity, and hardness scores, then often diminished by 12 months.
The total human evidence is small: a 2024 *Asian Journal of Urology* review counted roughly 11 trials, under 130 patients combined, and the 2025 *BMC Urology* meta-analysis could pool about 75 patients. That is tiny for a treatment costing thousands of dollars.
Exosomes are ~30 to 150 nm vesicles; the "message without the cell."
Across the regenerative-ED field, the AUA and the Sexual Medicine Society of North America (SMSNA) both classify these as investigational/experimental, to be offered within research protocols rather than as routine care.
Risks and Side Effects
Common and usually minor:
Pain, bruising, swelling, or tenderness at the injection site
Temporary redness or mild bleeding
More serious, especially with unregulated products:
The risks rise sharply when the product is poorly characterised or made by an unaccredited lab. A 2025 case series in the *Journal of Cosmetic Dermatology* documented persistent erythema, nodules, granulomatous inflammation, and scarring after injection of exosome-based formulations, with incomplete resolution despite corticosteroids, laser, and even surgery. The FDA's exosome safety notification followed serious adverse events including infections; reported harms from unapproved cell and exosome products have included infection, tumour formation, and, in non-genital uses, blindness.
Seek urgent medical care if, after a procedure, you develop:
Spreading redness, swelling, severe or worsening pain, or pus (signs of infection)
Fever or chills
A persistent, painful erection lasting more than four hours (priapism is a urological emergency)
Sudden firm lumps, hardening, or a new bend in the penis
How to Choose a Safe Clinic (and the Red Flags)
The single biggest determinant of safety is not which therapy you pick, it is who performs it and where the product comes from. Look for:
A licensed physician, ideally a urologist or sexual-medicine specialist, leading the protocol, not a salesperson
A named, accredited source/lab for the cells or exosomes, with documentation of how they are characterised and tested for sterility
A proper workup (labs, Doppler) before anyone reaches for a needle
Honest, written informed consent that states the treatment is investigational and not guaranteed
A willingness to discuss proven alternatives first
Red flags that should end the conversation:
Guarantees of a "cure," before-and-after claims that sound too clean, or pressure to decide today
No physician involvement, or no clear answer about where the product is sourced and how it is tested
Marketing that hides the experimental status or claims FDA approval for exosomes (there is none)
Prices that are dramatically below the market, which usually means a smaller dose or an unverified product
The Bottom Line
Stem cells and exosomes are the most advanced regenerative tools in men's health, and both are biologically plausible. But plausible is not the same as proven. The human evidence for ED is early and shows short-term, often fading benefit; exosomes in particular lack robust human ED trials and have no FDA-approved product. The responsible way to use these therapies is as a carefully selected adjunct, chosen with a doctor, after proven options have been considered, with clear-eyed expectations about cost and uncertainty.
If you are weighing stem cells versus exosomes, the most valuable next step is not a price comparison, it is a proper consultation that evaluates your actual cause of ED and tells you honestly whether regenerative therapy is even the right tool for you. Book a consultation with Menscape Bangkok to get an individualised, evidence-based recommendation. This page is educational and is not a substitute for medical advice; any regenerative treatment requires a consultation and a physician's prescription.
Frequently Asked Questions
Are stem cell or exosome therapies FDA-approved for erectile dysfunction?
No. There is no FDA-approved exosome product for any use, and stem cell therapy for ED is classified as investigational by major bodies such as the AUA and SMSNA. In practice that means these are experimental treatments offered electively, not standard, approved care. A licensed physician should explain this status in writing before you proceed.
Which works better, stem cells or exosomes?
No head-to-head trial has settled it, so any confident claim of a winner is marketing rather than evidence. Stem cells have the larger (still small) human ED evidence base and a stronger theoretical case for regeneration, making them the more-studied choice for moderate-to-severe, nerve-related ED. Exosomes are less invasive and cheaper but have thinner human ED data. The right choice depends on your specific cause of ED, which is what a consultation determines.
How long do the results last?
In the pooled human stem cell trials, improvement appeared around six months and frequently diminished by twelve. Clinics often quote 6 to 12 months for exosomes, but that figure comes from internal observation, not controlled trials. Plan for the possibility of repeat sessions and reassessment rather than a one-time fix.
How much does it cost in Bangkok?
Indicatively, exosome sessions run about THB 35,000 to 90,000 and stem cell protocols about THB 90,000 to 250,000, with high-dose or combination packages reaching THB 250,000 to 550,000. At roughly THB 32 per USD that is about USD 1,100 to 17,200 depending on the protocol, often 50 to 70 percent below typical US and UK pricing. These are ranges to confirm at consultation, not quotes, and a cheaper headline price often means a smaller dose.
Is the procedure painful, and what is the downtime?
It is done under local anaesthetic or a penile block, so discomfort during the injection is usually limited. Afterward, expect mild soreness, swelling, or bruising for a few days. Most men return to normal activity quickly, with sexual activity typically resumed after the first week or two as advised by the clinic.
Are these treatments safe?
When performed by a licensed physician using a properly sourced, accredited, sterile product, common side effects are minor (bruising, soreness). The serious risks, infection, granulomas and scarring, and in rare reports tumour formation, are concentrated around unregulated or poorly characterised products. That is exactly why clinic selection and product sourcing matter more than which therapy you choose.
Should I try regenerative therapy before or after standard ED treatments?
Generally after. Proven options, oral PDE5 inhibitors, correcting low testosterone, and treating the cardiovascular and metabolic disease that often drives ED, should be evaluated first. ED can be an early sign of vascular disease, so a proper workup is more important than jumping to an injection. Regenerative therapy is best viewed as an adjunct for selected men, not a first-line cure.
Can stem cells and exosomes be combined?
Yes, and some Bangkok clinics offer combination protocols, sometimes with shockwave therapy. The rationale is to deliver both cells and signalling at once. However, combining experimental treatments also stacks cost and uncertainty, and no trial has shown the combination outperforms either therapy alone. Discuss whether the added expense is justified for your situation.
Who should not have these treatments?
Men with active or recent cancer (because these therapies promote cell growth and new blood vessels), active infection, unmanaged bleeding disorders, or unrealistic expectations are generally not candidates. Anyone unwilling to first address the underlying cardiovascular or metabolic causes of their ED should reconsider. Final candidacy is a medical decision made at consultation, not something to self-diagnose.
References
Erectile Dysfunction: AUA Guideline (2018)-guideline)
/)
/)
/)
/)
/)